Effects of visualization of successful revascularization on chest pain and quality of life in chronic coronary syndrome: study protocol for the multi-center, randomized, controlled PLA-pCi-EBO-pilot-trial
Autor: | Samuel Sossalla, Lars S. Maier, Florian Zeman, Norbert Frey, Michael Koller, Franziska Koll, Astrid Dempfle, Michael Wester |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Angina pectoris medicine.medical_treatment 610 Medizin Medicine (miscellaneous) Chronic coronary syndrome Coronary Artery Disease 030204 cardiovascular system & hematology Chest pain Angina Coronary artery disease Study Protocol 03 medical and health sciences Percutaneous Coronary Intervention 0302 clinical medicine Quality of life Internal medicine Humans Multicenter Studies as Topic Chronic coronary syndrome Stable coronary artery disease Placebo effect Angina pectoris Medicine Pharmacology (medical) Prospective Studies cardiovascular diseases 030212 general & internal medicine Randomized Controlled Trials as Topic ddc:610 lcsh:R5-920 Placebo effect business.industry Percutaneous coronary intervention medicine.disease Coronary arteries Clinical trial Treatment Outcome medicine.anatomical_structure Conventional PCI Quality of Life Stable coronary artery disease medicine.symptom lcsh:Medicine (General) business |
Zdroj: | Trials, Vol 21, Iss 1, Pp 1-11 (2020) Trials |
ISSN: | 1745-6215 |
DOI: | 10.1186/s13063-020-04710-7 |
Popis: | Background Stable coronary artery disease (CAD), recently termed chronic coronary syndrome (CCS), is a highly prevalent disease. Current treatment strategies often include a relevant placebo effect. The hypothesis is that visual angiographic demonstration of the coronary arteries before and after successful percutaneous coronary intervention (PCI) by itself reduces the symptom burden of stable CAD/CCS. Design and methods The PLA-pCi-EBO-pilot-trial is a prospective, multi-center, randomized, controlled investigator-initiated pilot trial to study the effect of visual demonstration of successful PCI on quality of life (QoL) and angina pectoris (AP) in patients with symptomatic stable CAD/CCS. All patients with stable CAD/CCS and successful PCI will be screened. One hundred forty four patients with a frequency of AP ≥ 2/week will be randomized 1:1 stratified for AP frequency > 1/day. The control group will receive the common written procedural report on the procedure. Patients in the intervention group will additionally be given a printout picture of their coronary angiogram both before and after PCI. Primary endpoints are change in the Seattle Angina Questionnaire (SAQ)-derived QoL score 1 and 6 months after PCI. Secondary endpoints are changes in other SAQ-derived scores and dyspnea (NYHA score) 1 and 6 months after PCI. Discussion The PLA-pCi-EBO-pilot-trial evaluates the effect of visual angiographic result demonstration on disease symptoms and QoL in patients with stable CAD/CCS on top of PCI. A positive outcome of our study would encourage the routine use of angiographic picture demonstration and has thus the potential to change daily routine in the catheterization laboratory. Trial registration German Clinical Trials Register DRKS00017524. Registered on 5 July 2019 |
Databáze: | OpenAIRE |
Externí odkaz: |